Format

Send to

Choose Destination
See comment in PubMed Commons below
Euro Surveill. 2011 Apr 7;16(14). pii: 19833.

Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.

Author information

1
Sexually Transmitted Bacteria Reference Laboratory, Health Protection Agency, London, United Kingdom. catherine.ison@hpa.org.uk

Abstract

Successful treatment of gonorrhoea is the mainstay of public health control. Cefixime and ceftriaxone, highly active third generation cephalosporins, are today the recommended first-line agents in most countries and azithromycin is a second-line agent. However, there is increasing evidence of decreasing susceptibility and emergence of therapeutic failures. In this report two cases of clinical failure to cefixime are described, one of which additionally shows failure to azithromycin and selection of a less susceptible strain during treatment.

PMID:
21492528
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for European Centre for Disease Prevention and Control (ECDC)
    Loading ...
    Support Center